venBio Partners L.P.

13F Portfolio Filings

  • Most recent 13F
    Q4 2018
  • Location
    san francisco, CA
  • CIK
    0001737053
  • All SEC filings
Q4 2018
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

3

$38.08M
Apellis Pharmaceuticals, Inc, VRNA, MNLOUSD
13F-HR
Feb 14, 2019
000101297519000159

3

$57.17M
Apellis Pharmaceuticals, Inc, MNLOUSD, VRNA
13F-HR
Nov 14, 2018
000173705318000003

4

$96.92M
Apellis Pharmaceuticals, Inc, VRNA, MNLOUSD, NABRIVA THERAPEUTICS PLC
13F-HR
Aug 14, 2018
000101297518001014

4

$162.25M
Apellis Pharmaceuticals, Inc, MNLOUSD, VRNA, NABRIVA THERAPEUTICS PLC
13F-HR
Apr 25, 2018
000173705318000002

3

$100.76M
Apellis Pharmaceuticals, Inc, NABRIVA THERAPEUTICS PLC, VRNA
13F-HR
Apr 25, 2018
000173705318000001